Home » Analyst Articles – Company Sum

Image for Certara (CERT) – Investment Analysts’ Weekly Ratings Changes

Certara (CERT) – Investment Analysts’ Weekly Ratings Changes

Certara (NASDAQ: CERT) recently received a number of ratings updates from brokerages and research firms: 5/29/2026 – Certara had its “sell (e+)” rating reaffirmed by Weiss Ratings. 5/12/2026 – Certara had its... More of this article »
Image for Recent Investment Analysts’ Ratings Updates for Everest Group (EG)

Recent Investment Analysts’ Ratings Updates for Everest Group (EG)

Everest Group (NYSE: EG) has recently received a number of price target changes and ratings updates: 5/22/2026 – Everest Group had its “hold (c)” rating reaffirmed by Weiss Ratings. 5/21/2026 – Everest Group... More of this article »
Image for Dycom Industries (DY) – Analysts’ Recent Ratings Updates

Dycom Industries (DY) – Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for Dycom Industries (NYSE: DY): 6/1/2026 – Dycom Industries had its price target raised by KeyCorp from $482.00 to $610.00. They now have an “overweight”... More of this article »
Image for RS Group (RS1) – Investment Analysts’ Weekly Ratings Updates

RS Group (RS1) – Investment Analysts’ Weekly Ratings Updates

A number of firms have modified their ratings and price targets on shares of RS Group (LON: RS1) recently: 5/21/2026 – RS Group had its “hold” rating reaffirmed by Deutsche Bank Aktiengesellschaft. They now have... More of this article »
Image for Recent Research Analysts’ Ratings Updates for Cactus (WHD)

Recent Research Analysts’ Ratings Updates for Cactus (WHD)

A number of firms have modified their ratings and price targets on shares of Cactus (NYSE: WHD) recently: 5/27/2026 – Cactus was downgraded by Weiss Ratings from “hold (c)” to “hold (c-)”. 5/20/2026 –... More of this article »
Image for Lexeo Therapeutics (LXEO) – Analysts’ Recent Ratings Changes

Lexeo Therapeutics (LXEO) – Analysts’ Recent Ratings Changes

Lexeo Therapeutics (NASDAQ: LXEO) has recently received a number of price target changes and ratings updates: 5/29/2026 – Lexeo Therapeutics was downgraded by Weiss Ratings from “sell (d-)” to “sell (e+)”. 5/16/2026... More of this article »
Image for Recent Investment Analysts’ Ratings Changes for Enbridge (ENB)

Recent Investment Analysts’ Ratings Changes for Enbridge (ENB)

A number of research firms have changed their ratings and price targets for Enbridge (TSE: ENB): 5/26/2026 – Enbridge had its price target raised by TD from C$73.00 to C$79.00. They now have a “hold” rating on the... More of this article »
Image for Recent Investment Analysts’ Ratings Updates for Hiscox (HSX)

Recent Investment Analysts’ Ratings Updates for Hiscox (HSX)

Hiscox (LON: HSX) has recently received a number of price target changes and ratings updates: 5/28/2026 – Hiscox had its “add” rating reaffirmed by Peel Hunt. They now have a GBX 1,960 price target on the stock. 5/18/2026... More of this article »
Image for Altius Minerals (ALS) – Investment Analysts’ Weekly Ratings Changes

Altius Minerals (ALS) – Investment Analysts’ Weekly Ratings Changes

A number of research firms have changed their ratings and price targets for Altius Minerals (TSE: ALS): 5/14/2026 – Altius Minerals had its price target raised by Raymond James Financial, Inc. from C$52.00 to C$59.00. 5/13/2026... More of this article »
Image for National Vision (EYE) – Analysts’ Recent Ratings Updates

National Vision (EYE) – Analysts’ Recent Ratings Updates

A number of firms have modified their ratings and price targets on shares of National Vision (NASDAQ: EYE) recently: 5/15/2026 – National Vision had its price target lowered by Citigroup Inc. from $40.00 to $39.00. They now... More of this article »
Image for NFI Group (NFI) – Investment Analysts’ Weekly Ratings Changes

NFI Group (NFI) – Investment Analysts’ Weekly Ratings Changes

A number of research firms have changed their ratings and price targets for NFI Group (TSE: NFI): 5/12/2026 – NFI Group had its price target raised by Stifel Nicolaus from C$25.50 to C$26.00. They now have a “buy”... More of this article »
Image for JAN (JAN) – Research Analysts’ Weekly Ratings Changes

JAN (JAN) – Research Analysts’ Weekly Ratings Changes

A number of firms have modified their ratings and price targets on shares of JAN (NYSE: JAN) recently: 5/27/2026 – JAN had its price target raised by Scotiabank from $28.00 to $30.00. They now have an “outperform”... More of this article »
Image for Investment Analysts’ Recent Ratings Updates for SAB Biotherapeutics (SABS)

Investment Analysts’ Recent Ratings Updates for SAB Biotherapeutics (SABS)

Several brokerages have updated their recommendations and price targets on shares of SAB Biotherapeutics (NASDAQ: SABS) in the last few weeks: 5/22/2026 – SAB Biotherapeutics is now covered by Citigroup Inc.. They set a “buy”... More of this article »
Image for Analysts’ Weekly Ratings Updates for Sandisk (SNDK)

Analysts’ Weekly Ratings Updates for Sandisk (SNDK)

A number of firms have modified their ratings and price targets on shares of Sandisk (NASDAQ: SNDK) recently: 5/29/2026 – Sandisk had its price target raised by Susquehanna from $2,000.00 to $3,250.00. They now have a “positive”... More of this article »
Image for Investment Analysts’ Weekly Ratings Updates for Crinetics Pharmaceuticals (CRNX)

Investment Analysts’ Weekly Ratings Updates for Crinetics Pharmaceuticals (CRNX)

A number of firms have modified their ratings and price targets on shares of Crinetics Pharmaceuticals (NASDAQ: CRNX) recently: 5/17/2026 – Crinetics Pharmaceuticals was upgraded by Wall Street Zen from “strong sell”... More of this article »
Image for Intel (INTC) – Analysts’ Recent Ratings Updates

Intel (INTC) – Analysts’ Recent Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of Intel (NASDAQ: INTC) in the last few weeks: 5/26/2026 – Intel was downgraded by Northland Securities from “outperform” to “market... More of this article »
Image for Research Analysts’ Recent Ratings Updates for Mirum Pharmaceuticals (MIRM)

Research Analysts’ Recent Ratings Updates for Mirum Pharmaceuticals (MIRM)

A number of firms have modified their ratings and price targets on shares of Mirum Pharmaceuticals (NASDAQ: MIRM) recently: 5/22/2026 – Mirum Pharmaceuticals was downgraded by Weiss Ratings from “sell (d)” to “sell... More of this article »
Image for International Seaways (INSW) – Research Analysts’ Recent Ratings Updates

International Seaways (INSW) – Research Analysts’ Recent Ratings Updates

A number of research firms have changed their ratings and price targets for International Seaways (NYSE: INSW): 5/27/2026 – International Seaways was upgraded by Zacks Research from “hold” to “strong-buy”. 5/18/2026... More of this article »
Image for Investment Analysts’ Weekly Ratings Changes for Keel Infrastructure (KEEL)

Investment Analysts’ Weekly Ratings Changes for Keel Infrastructure (KEEL)

Keel Infrastructure (NASDAQ: KEEL) recently received a number of ratings updates from brokerages and research firms: 5/11/2026 – Keel Infrastructure was given a new $5.50 price target by Lake Street Capital. 5/11/2026 –... More of this article »
Image for Presidio Production (FTW) – Research Analysts’ Weekly Ratings Changes

Presidio Production (FTW) – Research Analysts’ Weekly Ratings Changes

Several brokerages have updated their recommendations and price targets on shares of Presidio Production (NYSE: FTW) in the last few weeks: 5/23/2026 – Presidio Production was upgraded by Wall Street Zen from “sell”... More of this article »
Image for Recent Analysts’ Ratings Changes for Ethos Technologies Inc. Class A Common Stock (LIFE)

Recent Analysts’ Ratings Changes for Ethos Technologies Inc. Class A Common Stock (LIFE)

Ethos Technologies Inc. Class A Common Stock (NASDAQ: LIFE) has recently received a number of price target changes and ratings updates: 5/26/2026 – Ethos Technologies Inc. Class A Common Stock was downgraded by Weiss Ratings... More of this article »
Image for Weekly Research Analysts’ Ratings Updates for General Dynamics (GD)

Weekly Research Analysts’ Ratings Updates for General Dynamics (GD)

A number of firms have modified their ratings and price targets on shares of General Dynamics (NYSE: GD) recently: 5/23/2026 – General Dynamics was downgraded by Wall Street Zen from “strong-buy” to “buy”. 5/19/2026... More of this article »
Image for Research Analysts’ Recent Ratings Updates for Silvercrest Asset Management Group (SAMG)

Research Analysts’ Recent Ratings Updates for Silvercrest Asset Management Group (SAMG)

Silvercrest Asset Management Group (NASDAQ: SAMG) recently received a number of ratings updates from brokerages and research firms: 5/27/2026 – Silvercrest Asset Management Group was downgraded by Weiss Ratings from “hold... More of this article »
Image for Weekly Research Analysts’ Ratings Updates for American Electric Power (AEP)

Weekly Research Analysts’ Ratings Updates for American Electric Power (AEP)

A number of research firms have changed their ratings and price targets for American Electric Power (NASDAQ: AEP): 5/21/2026 – American Electric Power had its price target lowered by Morgan Stanley from $136.00 to $129.00. They... More of this article »
Image for Research Analysts’ Weekly Ratings Updates for Qiagen (QGEN)

Research Analysts’ Weekly Ratings Updates for Qiagen (QGEN)

Several analysts have recently updated their ratings and price targets for Qiagen (NYSE: QGEN): 5/18/2026 – Qiagen was given a new $36.00 price target by Stifel Nicolaus. They now have a “hold” rating on the stock. 5/18/2026... More of this article »